Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage (Q34144848)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage |
scientific article |
Statements
1 reference
Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage (English)
1 reference
Yuji Yamamoto
1 reference
Junji Matsui
1 reference
Tomohiro Matsushima
1 reference
Hiroshi Obaishi
1 reference
Kazuki Miyazaki
1 reference
Katsuji Nakamura
1 reference
Osamu Tohyama
1 reference
Taro Semba
1 reference
Atsumi Yamaguchi
1 reference
Sachi Suzuki Hoshi
1 reference
Fusayo Mimura
1 reference
Toru Haneda
1 reference
Yoshio Fukuda
1 reference
Jun-Ichi Kamata
1 reference
Keiko Takahashi
1 reference
Masayuki Matsukura
1 reference
Toshiaki Wakabayashi
1 reference
Makoto Asada
1 reference
Ken-Ichi Nomoto
1 reference
Tatsuo Watanabe
1 reference
Zoltan Dezso
1 reference
Kentaro Yoshimatsu
1 reference
Yasuhiro Funahashi
1 reference
Akihiko Tsuruoka
1 reference
6 September 2014
1 reference
1 reference
18
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference